NVAX
Price
$6.80
Change
+$0.04 (+0.59%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
1.1B
34 days until earnings call
VERV
Price
$11.28
Change
+$0.07 (+0.62%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
1B
35 days until earnings call
Interact to see
Advertisement

NVAX vs VERV

Header iconNVAX vs VERV Comparison
Open Charts NVAX vs VERVBanner chart's image
Novavax
Price$6.80
Change+$0.04 (+0.59%)
Volume$152.9K
Capitalization1.1B
Verve Therapeutics
Price$11.28
Change+$0.07 (+0.62%)
Volume$70.36K
Capitalization1B
NVAX vs VERV Comparison Chart in %
Loading...
NVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVAX vs. VERV commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVAX is a StrongBuy and VERV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (NVAX: $6.80 vs. VERV: $11.28)
Brand notoriety: NVAX: Notable vs. VERV: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVAX: 25% vs. VERV: 23%
Market capitalization -- NVAX: $1.1B vs. VERV: $1B
NVAX [@Biotechnology] is valued at $1.1B. VERV’s [@Biotechnology] market capitalization is $1B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVAX’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • NVAX’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, VERV is a better buy in the long-term than NVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVAX’s TA Score shows that 4 TA indicator(s) are bullish while VERV’s TA Score has 6 bullish TA indicator(s).

  • NVAX’s TA Score: 4 bullish, 5 bearish.
  • VERV’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, VERV is a better buy in the short-term than NVAX.

Price Growth

NVAX (@Biotechnology) experienced а +4.62% price change this week, while VERV (@Biotechnology) price change was +0.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

NVAX is expected to report earnings on Aug 06, 2025.

VERV is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVAX($1.1B) has a higher market cap than VERV($1B). VERV YTD gains are higher at: 100.000 vs. NVAX (-15.423). NVAX has higher annual earnings (EBITDA): 555M vs. VERV (-201.62M). NVAX has more cash in the bank: 731M vs. VERV (497M). VERV has less debt than NVAX: VERV (68.6M) vs NVAX (229M). NVAX has higher revenues than VERV: NVAX (1.22B) vs VERV (59.6M).
NVAXVERVNVAX / VERV
Capitalization1.1B1B110%
EBITDA555M-201.62M-275%
Gain YTD-15.423100.000-15%
P/E Ratio2.47N/A-
Revenue1.22B59.6M2,039%
Total Cash731M497M147%
Total Debt229M68.6M334%
FUNDAMENTALS RATINGS
NVAX: Fundamental Ratings
NVAX
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
40
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVAXVERV
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 7 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
NVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPFZX32.14N/A
N/A
PGIM Jennison Focused Growth Z
SLCVX29.23N/A
N/A
Saratoga Large Capitalization Value I
FHEAX16.68N/A
N/A
Fidelity Advisor Real Estate A
BGLUX43.78N/A
N/A
Baron Global Advantage R6
VPRAX30.03N/A
N/A
VY® T. Rowe Price Capital Apprec R6

NVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVAX has been loosely correlated with MRNA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NVAX jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVAX
1D Price
Change %
NVAX100%
+0.59%
MRNA - NVAX
45%
Loosely correlated
+0.69%
ARCT - NVAX
43%
Loosely correlated
+1.17%
THRD - NVAX
42%
Loosely correlated
+0.18%
BNTX - NVAX
41%
Loosely correlated
+1.61%
CRSP - NVAX
39%
Loosely correlated
+0.97%
More

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with ACXP. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then ACXP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
+0.62%
ACXP - VERV
51%
Loosely correlated
-0.97%
CRSP - VERV
50%
Loosely correlated
+0.97%
BEAM - VERV
49%
Loosely correlated
+0.65%
IVEVF - VERV
46%
Loosely correlated
N/A
AXON - VERV
44%
Loosely correlated
+2.70%
More